TIDMAVCT

RNS Number : 7107M

Avacta Group PLC

11 May 2015

 
 Press Release   11 May 2015

Avacta Group plc

("Avacta" or the "Group")

Issue of Equity

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that 250,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by a former employee.

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 14 May 2015.

The total number of Ordinary Shares in issue following the above issue will be 4,979,399,550 each with voting rights. No Ordinary Shares are held in Treasury.

The above figure of 4,979,399,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

- Ends -

Enquiries:

 
 Avacta Group plc                                       Tel: +44 (0) 844 
                                                                414 0452 
 Alastair Smith, Chief Executive                          www.avacta.com 
  Officer 
 Tim Sykes, Chief Financial 
  Officer 
 
 Numis Securities Limited                               Tel: +44 (0) 207 
                                                                260 1000 
 Michael Meade / Freddie Barnfield                     www.numiscorp.com 
  - Nominated 
  Adviser 
 James Black - Corporate Broking 
 
 Walbrook PR Limited                   Tel: +44 (0) 20 7933 8780 
                                        or avacta@walbrookpr.com 
 Paul McManus                                   Mob: +44 (0)7890 541 893 
 Lianne Cawthorne                               Mob: +44 (0)7584 391 303

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through two divisions:

 
 Avacta Animal                 Veterinary diagnostics reference 
  Health                        laboratory and diagnostic kit 
  www.avactaanimalhealth.com    provider. 
----------------------------  --------------------------------------- 
 Avacta Life Sciences          Novel non-antibody affinity 
  www.avactalifesciences.com    reagents called Affimers, with 
                                a wide range of Life Science 
                                applications in diagnostics, 
                                drug and biomarker discover 
                                and biotech research and development. 
----------------------------  ---------------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEUKOORVKAVRAR

Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Avacta Charts.
Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Avacta Charts.